Literature DB >> 32862282

Living donor kidney transplantation is an effective option of renal replacement therapy in patients with light-chain amyloidosis (AL).

Elena Guillen1, Enrique Montagud-Marrahi2, Diana M Rodriguez2, Evelyn Hermida2, Raul A Padilla2,3, Miquel Blasco2, M Teresa Cibeira4, Rodrigo Martino5, Carlos Fernandez de Larrea4, J M Campistol2, Luis F Quintana2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32862282     DOI: 10.1007/s00277-020-04230-z

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  1 in total

Review 1.  Systemic amyloidosis: novel therapies and role of biomarkers.

Authors:  Mario Nuvolone; Giampaolo Merlini
Journal:  Nephrol Dial Transplant       Date:  2017-05-01       Impact factor: 5.992

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.